Edition:
International

Biotechnology & Medical Research

Minerva Neurosciences Posts Q1 Loss Per Share $0.21

May 12 (Reuters) - Minerva Neurosciences Inc ::MINERVA NEUROSCIENCES REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND BUSINESS UPDATES.Q1 LOSS PER SHARE $0.21.Q1 EARNINGS PER SHARE ESTIMATE $0.33 -- REFINITIV IBES DATA.CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT MARCH 31, 2021 WERE APPROXIMATELY...

7:30am EDT

Inflarx Posts Qtrly Loss Per Share Eur 0.18

May 12 (Reuters) - Inflarx NV ::INFLARX REPORTS FIRST QUARTER 2021 FINANCIAL & OPERATING RESULTS.INFLARX NV - CASH, CASH EQUIVALENTS AND FINANCIAL ASSETS OF APPROXIMATELY EUR 137.8 MILLION AS OF MARCH 31, 2021.INFLARX NV - QTRLY LOSS PER SHARE EUR 0.18.

7:30am EDT

Synairgen Reports Preliminary Results For The Year Ended December 31

May 12 (Reuters) - Synairgen PLC ::PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020.

7:00am EDT

Mergers & Acquisitions

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.